This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Zurich Heart Center Reports Excellent Early Clinical Experience With ESVS® Mesh At International Society Of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

Stocks in this article: KIPS

Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS) announced today that Prof. Michele Genoni, MD, Chief of Cardiovascular Surgery of the Triemli Hospital, Zurich, Switzerland, presented his center’s early clinical experience with the eSVS ® Mesh device at the 14 th Annual meeting of the ISMICS in Los Angeles, CA.

Since 2011, Prof. Genoni and his surgical team have implanted the eSVS Mesh in twenty (20) patients undergoing off-pump coronary artery bypass procedures (“OPCAB"). All patients received two arterial bypass grafts, using the left and right internal mammary arteries, and one saphenous vein graft (“SVG”), treated with the eSVS Mesh device, to the right coronary artery. The Kips Bay Medical eSVS Mesh is a knitted, nitinol prosthesis that is designed to fit around the outside of the saphenous vein so as to minimize the undesirable over-expansion which can cause graft failure. All bypass grafts were evaluated with computed tomography (“CT”) angiograms performed prior to the patient’s discharge from the hospital.

The data from these patients demonstrated excellent flow in the SVG grafts treated with the eSVS Mesh device. The results from these twenty patients showed that 95% of the saphenous vein grafts treated with the eSVS Mesh were open, or patent, and 100% of the arterial grafts were open.

Commenting on these results Prof. Genoni said, “We are very pleased with these early results utilizing the eSVS Mesh. OPCAB surgery can be more technically demanding and the eSVS Mesh is easy to use and fits well within our OPCAB program. Our next step is to follow these patients to collect longer term data.” Additionally, Manny Villafana, CEO, Founder and Chairman of Kips Bay Medical stated, “We congratulate Prof. Genoni and his team on their excellent initial results. These results reinforce and affirm the product and process improvements that we implemented after our first international trial. Kips Bay Medical remains committed to providing longer term follow-up evaluation on the safety and performance of the eSVS Mesh in CABG procedures. ”

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs